C07D 277/587
With aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to
Official title: with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. [IMAGE cpc-sch-C07D-1029.gif] with m >= 0, Z being a singly or a doubly bound hetero atom
C07D277/587 (With aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to) appears on 250 US grants and 67 published applications in this corpus.
Search patents in C07D- Granted patents
- 250
- Published applications
- 67
- Assignees
- 76
- Inventors
- 419
- Latest grant
- 1 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 2 | 0 |
| 1980 | 8 | 0 |
| 1981 | 20 | 0 |
| 1982 | 7 | 0 |
| 1983 | 15 | 0 |
| 1984 | 23 | 0 |
| 1985 | 19 | 0 |
| 1986 | 15 | 0 |
| 1987 | 19 | 0 |
| 1988 | 9 | 0 |
| 1989 | 15 | 0 |
| 1990 | 13 | 0 |
| 1991 | 9 | 0 |
| 1992 | 5 | 0 |
| 1993 | 4 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 7 | 0 |
| 1998 | 6 | 0 |
| 1999 | 4 | 0 |
| 2000 | 0 | 0 |
| 2001 | 4 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 1 | 1 |
| 2005 | 1 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 1 | 2 |
| 2010 | 2 | 3 |
| 2011 | 0 | 2 |
| 2012 | 2 | 3 |
| 2013 | 2 | 8 |
| 2014 | 3 | 5 |
| 2015 | 5 | 6 |
| 2016 | 1 | 3 |
| 2017 | 4 | 3 |
| 2018 | 5 | 5 |
| 2019 | 2 | 3 |
| 2020 | 1 | 3 |
| 2021 | 3 | 2 |
| 2022 | 3 | 4 |
| 2023 | 0 | 2 |
| 2024 | 1 | 1 |
| 2025 | 2 | 4 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Ribosome-mediated incorporation of peptides and peptidomimetics1 Apr 2025US 12,264,318 B2Arizona Board of Regents on behalf of Arizona State University
- Compounds as NLRP3 inflammasome inhibitors and compositions and uses thereof11 Feb 2025US 12,221,406 B2Virginia Commonwealth University
- Drug-conjugates, conjugation methods, and uses thereof15 Oct 2024US 12,115,228 B2Concortis Biosystems, Corp.
- Ribosome-mediated incorporation of peptides and peptidomimetics6 Sep 2022US 11,434,492 B2Arizona Board of Regents on behalf of Arizona State University
- (S)-n-hydroxy-2-(2-(4-methoxyphenyl)butanamido)thiazole-5-carboxamide and pharmaceutically acceptable salts thereof23 Aug 2022US 11,420,947 B2Translational Drug Development, LLC
- Compositions and methods for inhibiting type i collagen production25 Jun 2026US 2026/0174738 A1The Florida State University Research Foundation, Inc.
- Novel heterocyclic compound, salt thereof, and luminescent substrate composition4 Dec 2025US 2025/0368636 A1The University of Electro-Communications
- Process for the preparation of diversely substituted cyanocyclopropyl-heterocycles or arenes31 Jul 2025US 2025/0243169 A1Syngenta Crop Protection AG
- Ribosome-Mediated Incorporation of Peptides and Peptidomimetics19 Jun 2025US 2025/0197869 A1Arizona Board of Regents on behalf of Arizona State University
- Drug-Conjugates, Conjugation Methods, And Uses Thereof1 May 2025US 2025/0135024 A1Concortis Biosystems, Corp.
Most cited
By later US patents
- Cephem derivative162US 4,278,793 AHoechst Aktiengesellschaft · 1981
- Thiazolylacetamido cephalosporin type compounds148US 4,098,888 ATakeda Chemical Industries, Ltd. · 1978
- (6R,7R)-7-[(Z)-2-(2-Aminothiazol-4-yl)-2-(2-carboxyprop-2-oxyimino)ac etamido]-3-(1-pyridiniummethyl)-ceph-3-em-4-carboxylate and salts thereof86US 4,258,041 AGlaxo Group Limited · 1981
- 3-Acetoxymethyl-7-(iminoacetamido)-cephalosporanic acid derivatives77US 4,152,432 ARoussel Uclaf · 1979
- Syn 7-oxoimino substituted derivatives of cephalosporanic acid67US 4,166,115 AFujisawa Pharmaceutical Co., Ltd. · 1979